Clinica - Analysis

Clinica Scrip Scrip Regulatory Affairs Scrip Clinical Research Animal Pharm

Advanced Search

clinica

Home - Analysis

ANALYSIS

Lessons to be learned courtesy of PIP

19 January 2012

Who is really to blame for the implantation of sub-standard PIP breast implants and what can be done to close any regulatory loopholes? Senior medtech expert Jeremy Tinkler* looks at some of the background factors that can throw light on the issue ...

Companion Dx activity shines new light on IVD sector - is it all good?

04 January 2012

Developments on the regulatory and business front in the area of companion diagnostics made 2011 a pivotal year for both personalised medicine as a concept and for IVD manufacturers as a group. But might stricter regulation hinder testing in ...

Clinica 100: What lies ahead for US device regulation

01 December 2011

The jury is still out as to how the US regulatory system is going to evolve in the long term, but change it will. As the FDA gathers feedback on the IOM's damning report on the 510(k) system and the recommended changes, Glenn Neuman, director of ...

Auto injector market focuses on finer needles 20 May 2011

The auto injector market is a growing segment, but single-dose, self-administered delivery does not suit all drugs, says Cambridge Consultants drug delivery expert Phil Lever. Interview by Ashley Yeo The auto injector market has seen a lot of ...

>> More Analysis...

EXPERT VIEW

Softening CRM sector in need of more pace and rhythm

03 February 2012

Cardiac rhythm management remains a $2bn business at Boston Scientific , but a 15% slide (in both reported and constant currencies) in sales in the final quarter of 2011, reported yesterday, meant that the group’s second-largest business unit ...

Today Illumina; tomorrow the world? Where the acquisition might really take Roche

26 January 2012

Hoffmann-La Roche wants to acquire the San Diego-based gene sequencing and array diagnostic company Illumina, and the fact that it is willing to engage in a hostile takeover of the company and start the bidding in that process at a 64% premium to ...

“Saudi spring” 2012-style signals new growth for medtech

24 January 2012

Arab Health 2012, the largest healthcare exhibition in the Middle East, is currently in full swing at the Dubai World Trade Centre, UAE. Organised by Informa Exhibitions ( http://www.arabhealthonline.com/home/ ), the event runs from January ...

Medtech regulatory debate needs to tackle risk/benefit of aesthetic vs medical products

19 January 2012

What is largely absent from the PIP-provoked global medtech regulatory debate is the reminder that the products at the heart of the scandal are primarily used for cosmetic purposes, and that the argument for stricter, more independent scrutiny of ...

>> More Expert View...

PATENT WATCH

Organovo's bioprinter for new tissue and EStimME expands into middle ear drug delivery

24 November 2011

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

Human hair gives strength to new hydrogel and more cancer companion Dx

27 September 2011

Clinica’s Patent Watch looks at the most interesting patent applications published in July/August 2011. It focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised ...

Magnetically-enhanced cell therapy and Philips' cancer biomarkers for personalised treatment

19 July 2011

As of this edition, Clinica’s Patent Watch has changed its focus to medtech areas which are witnessing fast growth. These include regenerative medicine, drug delivery and emerging areas within personalised medicine such as molecular diagnostics. New ...

Nanoscale diamonds that reinforce polymers and thermoregulation of electromagnets within MRI equipment 01 June 2011

This edition of Clinica's Patent Watch looks at the most interesting patent applications in March and April 2011. These include diamond-reinforced implants, low-cost MRI technology and a technology for stabilising plaque in blood vessels. By Phil ...

>> More Patent Watch...

EVENTS

The 14th MedTech Investing Europe conference

19 March 2012

Montreux Convention and Music Centre, Switzerland

HTAi 2012

23 June 2012

Bilbao, Spain

This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36

Home

Market Sector

Business

Policy & Regulation

Regions

Scrip Regulatory Affairs

Scrip Clinical Research

Animal Pharm